Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Operating Expenses | 20,398 | 14,591 | 10,312 | 5,221 | 6,082 |
| Operating Income | -20,398 | -14,591 | -10,312 | -5,221 | -6,082 |
| Other Income | 165 | -918 | -1,843 | 1,145 | -309 |
| Pre-tax Income | -20,233 | -15,509 | -12,155 | -4,076 | -6,391 |
| Net Income Continuous | -20,233 | -15,509 | -12,155 | -4,076 | -6,391 |
| Net Income | $-20,233 | $-15,509 | $-12,155 | $-4,076 | $-6,391 |
| EPS Basic Total Ops | -0.25 | -0.24 | -0.27 | -0.14 | -0.29 |
| EPS Basic Continuous Ops | -0.25 | -0.24 | -0.27 | -0.14 | -0.29 |
| EPS Diluted Total Ops | -0.25 | -0.24 | -0.27 | -0.14 | -0.29 |
| EPS Diluted Continuous Ops | -0.25 | -0.24 | -0.27 | -0.14 | -0.29 |
| EBITDA(a) | $-20,364 | $-14,565 | $-10,289 | $-5,210 | $-6,039 |